245 related articles for article (PubMed ID: 9839294)
1. Effects of antihypertensive therapy on progression of diabetic nephropathy.
Luño J; Garcia de Vinuesa S; Gomez-Campdera F; Lorenzo I; Valderrábano F
Kidney Int Suppl; 1998 Dec; 68():S112-9. PubMed ID: 9839294
[TBL] [Abstract][Full Text] [Related]
2. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
3. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
Baba T; Ishizaki T
Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
[TBL] [Abstract][Full Text] [Related]
5. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
6. [Risk and prevention of diabetic nephropathy].
Ravera M; Re M; Deferrari G
G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
[TBL] [Abstract][Full Text] [Related]
7. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.
Jacobsen P; Rossing K; Parving HH
Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
9. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
Cooper ME
J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic management of diabetic nephropathy.
Vivian EM; Rubinstein GB
Clin Ther; 2002 Nov; 24(11):1741-56; discussion 1719. PubMed ID: 12501871
[TBL] [Abstract][Full Text] [Related]
11. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
12. Hypertension and antihypertensive treatment of diabetic nephropathy.
Ritz E; Dikow R
Nat Clin Pract Nephrol; 2006 Oct; 2(10):562-7. PubMed ID: 17003835
[TBL] [Abstract][Full Text] [Related]
13. Renal protection in diabetes--an emerging role for calcium antagonists.
Parving HH; Tarnow L; Rossing P
Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296
[TBL] [Abstract][Full Text] [Related]
14. The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes.
Lewis EJ
Am J Hypertens; 2002 Oct; 15(10 Pt 2):123S-128S. PubMed ID: 12383593
[TBL] [Abstract][Full Text] [Related]
15. Renal protection in diabetes: an emerging role for calcium antagonists.
Parving HH; Tarnow L; Rossing P
J Hypertens Suppl; 1996 Nov; 14(4):S21-5. PubMed ID: 8986939
[TBL] [Abstract][Full Text] [Related]
16. Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy.
Sato A; Tabata M; Hayashi K; Saruta T
Clin Exp Nephrol; 2003 Sep; 7(3):215-20. PubMed ID: 14586718
[TBL] [Abstract][Full Text] [Related]
17. Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group.
Jerums G; Allen TJ; Gilbert RE; Hammond J; Cooper ME; Campbell DJ; Raffaele J
J Diabetes Complications; 1995; 9(4):308-14. PubMed ID: 8573754
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for the management of special populations: renal disease in diabetes.
Raij L
Am J Hypertens; 2003 Nov; 16(11 Pt 2):46S-49S. PubMed ID: 14625161
[TBL] [Abstract][Full Text] [Related]
19. [Antihypertensive therapy in diabetes mellitus].
Hess B
Ther Umsch; 1999 Jan; 56(1):25-32. PubMed ID: 10067131
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
Thomas MC; Atkins RC
Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
